@jcommbiotech

Journal of Commercial Biotechnology is a quarterly peer-reviewed journal focused on the business of biotechnology. Free sample papers at http://t.co/Jf2NAojbvd

 Washington, DC
CommercialBiotechnology.com
Joined March 2011
  • Tweets7K
  • Following142
  • Followers3.4K
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech10 Sep 2021
The Code Breaker: Jennifer Doudna, gene editing, and the future of the human race commercialbiotechnology.com/…
1
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech9 Sep 2021
Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent commercialbiotechnology.com/…
2
3
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech8 Sep 2021
A Note on Corporate Open Innovation: Engagement with Startups commercialbiotechnology.com/…
2
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech7 Sep 2021
Putting Theory into Practice at BridgeBio commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech6 Sep 2021
Illumina Accelerator: Next-Gen Corporate Accelerator with a Customer-Creation Focus commercialbiotechnology.com/…
2
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech5 Sep 2021
A Case Study - NeuBase Therapeutics, Inc. commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech4 Sep 2021
Building technology enabled platform companies in Biopharma – a perspective on early-stage value creation from Millennium, Alnylam, Moderna, & Kymera commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech3 Sep 2021
Foundational Tools for Building a New Bioeconomy commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech2 Sep 2021
Abridge: A mission driven approach to machine learning for healthcare conversation commercialbiotechnology.com/…
3
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech3 Jan 2022
Value over Volume: Maximizing Resources by Prioritizing Value: The Dubai Healthcare Experience commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech3 Jan 2022
Using Lean Startup to Discover Customers in the mHealth Industry: Current Landscape and Challenges commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech1 Jan 2022
Bioentrepreneurship education: where have we been and where to next? commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech31 Dec 2021
Vaccine Hesitancy: When Political Miscommunication Replaces Scientific Benefit/Risk Assessment commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech30 Dec 2021
A System Review of Bioentrepreneurship Education commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech22 Dec 2021
Platform technology management of biotechnology companies in Japan commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech21 Dec 2021
CONSENSUS ON METRICS FOR THE ASSESSMENT OF A MEDICAL SCIENCE LIAISON USING THE DELPHI METHOD commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech29 Dec 2021
A conversation on accelerating innovation in biopharma and life sciences through global collaboration and alliances commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech28 Dec 2021
A Note From the Editor in Chief commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech27 Dec 2021
Considerations for Potential Global Expansion of Serum Institute of India commercialbiotechnology.com/…
1
Yali Friedman, Ph.D. retweeted
Yali Friedman, Ph.D.@jcommbiotech27 Dec 2021
The Role of the Biotechnology Industry in Addressing Health Inequities in Africa: Strengthening the Entire Health Care Value Chain commercialbiotechnology.com/…
1
Load more